NASDAQ: BBLGBone Biologics Corp Stock Ownership - Who owns Bone Biologics?
Insider buying vs selling
Have Bone Biologics Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Deina H. Walsh | Chief Financial Officer | 2023-09-13 | 8,000 | $0.64 | $5.12kBuy |
| Jeff Frelick | Chief Executive Officer | 2023-09-11 | 9,500 | $0.69 | $6.53kBuy |
| Deina H. Walsh | Chief Financial Officer | 2023-09-06 | 6,700 | $0.71 | $4.76kBuy |
| Deina H. Walsh | Chief Financial Officer | 2023-09-06 | 300 | $0.70 | $210.00Buy |
| Jeff Frelick | Chief Executive Officer | 2023-08-31 | 7,600 | $0.66 | $5.02kBuy |
BBLG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BBLG insiders and whales buy or sell their stock.
BBLG Shareholders
What type of owners hold Bone Biologics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Don Hankey | 1,254.50% | 6,702,016 | $11.25M | Insider |
| Jeff Frelick | 0.40% | 2,151 | $3.61k | Insider |
| Deina H. Walsh | 0.35% | 1,875 | $3.15k | Insider |
| Tower Research Capital LLC Trc | 0.23% | 1,225 | $2.06k | Institution |
| Wells Fargo Company | 0.00% | 4 | $6.71 | Institution |
| Robert E. Gagnon | 0.00% | 0 | $0.00 | Insider |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
BBLG vs Medical Device Stocks
Bone Biologics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.